124 related articles for article (PubMed ID: 10678637)
1. Sodium channel blockers and uridine triphosphate: effects on nasal potential difference in cystic fibrosis mice.
Ghosal S; Taylor CJ; Colledge WH; Ratcliff R; Evans MJ
Eur Respir J; 2000 Jan; 15(1):146-50. PubMed ID: 10678637
[TBL] [Abstract][Full Text] [Related]
2. Modification of nasal membrane potential difference with inhaled amiloride and loperamide in the cystic fibrosis (CF) mouse.
Ghosal S; Taylor CJ; McGaw J
Thorax; 1996 Dec; 51(12):1229-32. PubMed ID: 8994520
[TBL] [Abstract][Full Text] [Related]
3. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis.
Knowles MR; Clarke LL; Boucher RC
N Engl J Med; 1991 Aug; 325(8):533-8. PubMed ID: 1857389
[TBL] [Abstract][Full Text] [Related]
4. Minor role of Cl- secretion in non-cystic fibrosis and cystic fibrosis human nasal epithelium.
Rückes-Nilges C; Weber U; Lindemann H; Münker G; Clauss W; Weber WM
Cell Physiol Biochem; 1999; 9(1):1-10. PubMed ID: 10352340
[TBL] [Abstract][Full Text] [Related]
5. UTP inhibits Na+ absorption in wild-type and DeltaF508 CFTR-expressing human bronchial epithelia.
Devor DC; Pilewski JM
Am J Physiol; 1999 Apr; 276(4):C827-37. PubMed ID: 10199813
[TBL] [Abstract][Full Text] [Related]
6. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.
Smith SN; Middleton PG; Chadwick S; Jaffe A; Bush KA; Rolleston S; Farley R; Delaney SJ; Wainwright B; Geddes DM; Alton EW
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):129-34. PubMed ID: 9870926
[TBL] [Abstract][Full Text] [Related]
7. Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo.
Knowles MR; Clarke LL; Boucher RC
Chest; 1992 Mar; 101(3 Suppl):60S-63S. PubMed ID: 1541209
[No Abstract] [Full Text] [Related]
8. Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice.
Grubb BR; Vick RN; Boucher RC
Am J Physiol; 1994 May; 266(5 Pt 1):C1478-83. PubMed ID: 7515571
[TBL] [Abstract][Full Text] [Related]
9. The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis.
Rodgers HC; Knox AJ
Eur Respir J; 1999 Sep; 14(3):693-6. PubMed ID: 10543294
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of amiloride-sensitive epithelial Na(+) absorption by extracellular nucleotides in human normal and cystic fibrosis airways.
Mall M; Wissner A; Gonska T; Calenborn D; Kuehr J; Brandis M; Kunzelmann K
Am J Respir Cell Mol Biol; 2000 Dec; 23(6):755-61. PubMed ID: 11104728
[TBL] [Abstract][Full Text] [Related]
11. Potential difference measurements of ocular surface Na+ absorption analyzed using an electrokinetic model.
Levin MH; Kim JK; Hu J; Verkman AS
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):306-16. PubMed ID: 16384978
[TBL] [Abstract][Full Text] [Related]
12. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice.
Jiang C; Akita GY; Colledge WH; Ratcliff RA; Evans MJ; Hehir KM; St George JA; Wadsworth SC; Cheng SH
Hum Gene Ther; 1997 Apr; 8(6):671-80. PubMed ID: 9113507
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Ca2+-activated Cl- secretion by basolateral K+ channels in human normal and cystic fibrosis airway epithelia.
Mall M; Gonska T; Thomas J; Schreiber R; Seydewitz HH; Kuehr J; Brandis M; Kunzelmann K
Pediatr Res; 2003 Apr; 53(4):608-18. PubMed ID: 12612194
[TBL] [Abstract][Full Text] [Related]
14. [Benzamil and mucoviscidosis. Primary culture of nasal mucosa as an electrophysiologic in vitro model].
Blank U; Glanz H; Eistert B; Fryen A; Lindemann H; Hüls G; Clauss W; Weber WM
HNO; 1996 Apr; 44(4):172-7. PubMed ID: 8655347
[TBL] [Abstract][Full Text] [Related]
15. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis.
Hofmann T; Stutts MJ; Ziersch A; Rückes C; Weber WM; Knowles MR; Lindemann H; Boucher RC
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1844-9. PubMed ID: 9620916
[TBL] [Abstract][Full Text] [Related]
16. Relative ion permeability of normal and cystic fibrosis nasal epithelium.
Knowles M; Gatzy J; Boucher R
J Clin Invest; 1983 May; 71(5):1410-7. PubMed ID: 6853720
[TBL] [Abstract][Full Text] [Related]
17. Insights into the variability of nasal potential difference, a biomarker of CFTR activity.
Kyrilli S; Henry T; Wilschanski M; Fajac I; Davies JC; Jais JP; Sermet-Gaudelus I
J Cyst Fibros; 2020 Jul; 19(4):620-626. PubMed ID: 31699569
[TBL] [Abstract][Full Text] [Related]
18. Development of primary human nasal epithelial cell cultures for the study of cystic fibrosis pathophysiology.
de Courcey F; Zholos AV; Atherton-Watson H; Williams MT; Canning P; Danahay HL; Elborn JS; Ennis M
Am J Physiol Cell Physiol; 2012 Dec; 303(11):C1173-9. PubMed ID: 23015550
[TBL] [Abstract][Full Text] [Related]
19. CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor.
Salinas DB; Pedemonte N; Muanprasat C; Finkbeiner WF; Nielson DW; Verkman AS
Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L936-43. PubMed ID: 15246976
[TBL] [Abstract][Full Text] [Related]
20. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
